Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function

Area of Science:

• Immunology
• Cell Biology

Background:

• CD4+ CD25+ regulatory T cells are well-understood, but CD8+ T cell regulatory counterparts remain less explored.
• Regulatory T cells play a crucial role in maintaining immune homeostasis and preventing autoimmunity.

Purpose of the Study:

• To identify and characterize a novel regulatory T cell subset within the human CD8+ T cell population.
• To investigate the phenotype, function, and potential therapeutic applications of these newly identified CD8+ regulatory T cells.

Main Methods:

• Expansion and cloning of CD8+ T cells using autologous LPS-activated dendritic cells.
• Analysis of cell phenotype, cytokine production (IL-4, IL-5, IL-13, TGF-beta1, IFN-gamma), and suppressive function in vitro.
• Assessment of cell surface markers including CTLA-4 and Foxp3.

Main Results:

• Novel human CD8+ T cells with regulatory phenotype and function were identified.
• These cells are non-cytolytic, autoreactive, HLA class I-restricted, and produce IL-4, IL-5, IL-13, and TGF-beta1.
• They express CD69, CD25, CTLA-4, and Foxp3, suppress CD4+ T cell proliferation and IFN-gamma production via cell contact dependent on CTLA-4, and are increased in ankylosing spondylitis patients.

Conclusions:

• The identified CD8+ T cells represent the functional counterparts of CD4+ CD25+ regulatory T cells.
• These cells may be upregulated in inflammatory conditions like ankylosing spondylitis.
• Human CD8+ regulatory T cells have potential therapeutic applications, particularly in modulating immune responses.